Mechanical thrombectomy for the treatment of primary and secondary distal medium-vessel occlusion stroke: systematic review and meta-analysis

医学 冲程(发动机) 荟萃分析 溶栓 置信区间 改良兰金量表 脑出血 闭塞 子群分析 内科学 外科 心肌梗塞 缺血性中风 缺血 蛛网膜下腔出血 机械工程 工程类
作者
Aarón Rodríguez-Calienes,Juan Vivanco‐Suarez,J Sequeiros,Milagros Galecio‐Castillo,Cynthia Zevallos,Mudassir Farooqui,Santiago Ortega‐Gutiérrez
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:15 (e3): e460-e467 被引量:39
标识
DOI:10.1136/jnis-2022-019975
摘要

Background There is limited evidence on the indication and role of mechanical thrombectomy (MT) in patients with distal medium-vessel occlusions (DMVOs). The aim of this systematic review and meta-analysis was to evaluate all the evidence available on the efficacy and safety of MT techniques (stent retriever, aspiration) in primary and secondary DMVOs. Methods Five databases were searched from inception to January 2023 for studies of MT in primary and secondary DMVOs. Outcomes of interest included favorable functional outcome (90-day modified Rankin scale (mRS) 0–2), successful reperfusion (modified Thrombolysis in Cerebral Infarction (mTICI) 2b-3), symptomatic intracerebral hemorrhage (sICH), and 90-day mortality. Prespecified subgroup meta-analyses according to the specific MT technique and to the vascular territory (distal M2-M5, A2-A5, P2-P5) were also performed. Results A total of 29 studies with 1262 patients were included. For primary DMVOs (n=971 patients), pooled rates of successful reperfusion, favorable outcome, 90-day mortality and sICH were 84% (95% confidence interval (CI) 76 to 90%), 64% (95% CI 54 to 72%), 12% (95% CI 8 to 18%), and 6% (95% CI 4 to 10%), respectively. For secondary DMVOs (n=291 patients), pooled rates of successful reperfusion, favorable outcome, 90-day mortality and sICH were 82% (95% CI 73 to 88%), 54% (95% CI 39 to 69%), 11% (95% CI 5 to 20%), and 3% (95% CI 1 to 9%), respectively. Subgroup analyses by MT technique and by vascular territory showed no differences in primary and secondary DMVOs. Conclusion Our findings suggest that MT using aspiration or stent retriever techniques appears to be effective and safe in primary and secondary DMVOs. However, given the level of evidence of our results, further confirmation in well-designed randomized controlled trials is needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yy完成签到,获得积分10
1秒前
goudali完成签到,获得积分10
1秒前
1秒前
1秒前
匿名发布了新的文献求助10
2秒前
活力薯片完成签到,获得积分10
3秒前
3秒前
柳智敏完成签到,获得积分10
3秒前
3秒前
JamesPei的应助被11采纳,获得10
4秒前
4秒前
455发布了新的文献求助10
5秒前
6秒前
6秒前
xxslzw完成签到,获得积分10
7秒前
星焕辰兮发布了新的文献求助30
7秒前
7秒前
niaho完成签到,获得积分10
7秒前
xiang发布了新的文献求助10
7秒前
胖胖发布了新的文献求助10
8秒前
8秒前
科研通AI2S的应助被重要元灵采纳,获得10
8秒前
爱学习的杰杰杰完成签到,获得积分10
9秒前
芽芽乐发布了新的文献求助10
10秒前
斯文败类的应助被老迟到的涫采纳,获得10
11秒前
xgx984完成签到,获得积分10
12秒前
12秒前
绫楪樱花完成签到,获得积分10
12秒前
深情安青的应助被蔡蔡采纳,获得30
13秒前
慕青的应助被无机采纳,获得10
13秒前
龅牙苏发布了新的文献求助10
14秒前
14秒前
14秒前
15秒前
Thea发布了新的文献求助10
15秒前
15秒前
15秒前
隐形曼青的应助被aa121599采纳,获得10
16秒前
自觉从筠完成签到 ,获得积分10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea De Guyane 2000
内視鏡下経鼻経蝶形骨洞手術術後SIADHに対する予防的水制限の安全性と有効性の検討 1000
Problems and Solutions for Integer and Combinatorial Optimization: Building Skills in Discrete Optimization 600
Organizational Behavior 510
桑白皮エキスの実験的, 臨床的育毛効果について 500
Nonlinear vehicle active suspension system control method based on the extended high gain observer 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8001654
求助须知:如何正确求助?哪些是违规求助? 9454186
关于积分的说明 21148552
捐赠科研通 7574334
什么是DOI,文献DOI怎么找? 3381312
关于科研通互助平台的介绍 2514046
邀请新用户注册赠送积分活动 2415560